| Affiliation: | 1. Umeå University, Umeå, Sweden;2. Lund University, Lund, Sweden;3. Charité—Universitätsmedizin Berlin, Berlin, Germany;4. Universidad de Chile, Santiago, Chile;1. HM CINAC, Hospital Universitario HM Puerta del Sur, Mostoles, Madrid, Spain;2. Universidad CEU San Pablo, Madrid, Spain;3. Center for Networked Biomedical Research on Neurodegenerative Diseases (CIBERNED), Madrid, Spain;4. Champalimaud Neuroscience Programme, Champalimaud Centre for the Unknown, Lisbon, Portugal;5. Departments of Neuroscience and Neurology, Zuckerman Mind Brain Behavior Institute, Columbia University, New York, NY, USA;6. Department of Psychology, University of Sheffield, Sheffield, S10 2TN, UK;1. Laboratory of Neuroscience and Behavior, Institute of Biological Sciences, Universidade de Brasília (UnB); Neurology Section, Medical Department, Chamber of Deputies of the Federal Republic of Brazil, Brasília, DF, Brazil;2. Toronto Western Hospital, Movement Disorders Centre, Toronto Western Hospital – UHN, Division of Neurology, University of Toronto, Toronto, Canada;3. Laboratory of Neuroscience and Behavior, Institute of Biological Sciences, Universidade de Brasília (UnB); Movement Disorders Group, Neurology Unit, Hospital de Base do Distrito Federal; School of Medicine, Centro Universitário de Brasília (UniCEUB), Brasília, DF, Brazil;4. Movement Disorders Unit, Internal Medicine Department, Neurology Service, Universidade Federal de Minas Gerais (UFMG), Belo Horizonte, MG, Brazil;5. School of Medicine, Centro Universitário de Brasília (UniCEUB), Brasília, DF, Brazil;6. Technology for Gene Therapy Laboratory, Central Institute of Sciences, University of Brasília/FAV, Brasília, DF, Brazil;7. Laboratory of Neuroscience and Behavior and Graduate Program in Environment, CEUMA University – UniCEUMA, São Luís, MA, Brazil;8. Laboratory of Neuroscience and Behavior, Institute of Biological Sciences, Universidade de Brasília (UnB), Brasília, DF, Brazil |
